New Zealand

 

75 years on: is the future of the NHS private?

The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

What does Kiwi deal tell us about Bupa’s plans?

Bupa appears to be selling off its New Zealand nursing home arm. What does this mean for the rest of its huge health care services portfolio – which generated revenue of £3.74bn in 2021 – and of its long-term strategy?

US homecare tech specialist buys Home Instead

US-based homecare tech specialist Honor Technology has acquired Home Instead, the global leader of franchise homecare services. The deal creates a global homecare group worth more than $2.1 billion in homecare revenue.  HBI chats with sources including Home Instead's UK CEO to find out what the deal means for markets outside of the United States.

Bupa shift towards digital could impact M&A

Bupa’s new CEO Iñaki Ereño has announced a new strategy for the international health insurer and service group including making 40% of customer care touchpoints Bupa-owned, and having 60% active digital customers. What does this mean for Bupa's M&A strategy going forward? We talk to consultancy Candesic to find out more.

Suitors line up to buy $1bn Fullerton

Private equity firms Coalition Capital Partners and Warburg Pincus are reportedly short-listed to acquire South East Asian healthcare services provider Fullerton Healthcare Group for $1 billion.

FREE BLOG Is value health dead?

A decade ago value health was flying high. Launched by Harvard guru Michael Porter in 2006 the idea was enthusiastically espoused by Barak Obama and central to Obamacare. Then along came Trump. Meanwhile, the fiendish complexity of health care has stymied efforts. So where is it now? ICHOM 2019 in Rotterdam with 1,250 delegates was a great place to find out.

Find Us